Tourette Syndrome Therapeutics - Pipeline Assessment and Market Forecasts to 2019 On 1stDecember 2014
Summary The industry analysis specialist, has released its new report, “Tourette Syndrome Therapeutics - Pipeline Assessment and Market Forecasts to 2019�. The report is an essential source of information and analysis on the global Tourette Syndrome Therapeutics market. The report identifies the key trends shaping and driving the global Tourette Syndrome Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Tourette Syndrome Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
You can buy this Report @ http://www.jsbmarketresearch.com/healthcaremedical/r-tourette-syndrome-therapeutics-pipeline-assessment-and-marketforecasts-135218 Scope The report provides information on the key drivers and challenges of the Tourette Syndrome Therapeutics market. Its scope includes Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
- Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Tourette Syndrome Therapeutics market revenues data from 2006 to 2011, forecast for eight years to 2019. - Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes. - Analysis of the current and future competition in the seven key countries Tourette Syndrome Therapeutics market. - Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications. - Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Tourette Syndrome Therapeutics market. - Analysis of key recent licensing and partnership agreements in Tourette Syndrome Therapeutics market
Reasons to buy The report will enhance your decision making capability. It will allow you to - Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline. - Develop business strategies by understanding the trends shaping and driving the global Tourette Syndrome Therapeutics market. - Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Tourette Syndrome Therapeutics market in future. - Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors. - Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. - Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships. Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
- What’s the next big thing in the global Tourette Syndrome Therapeutics market landscape? – Identify, understand and capitalize.
Other industries we cover: • • • • • • • • •
Advertising and Media Automotive and Parts Consumer Goods Healthcare and Medical Finance and Banking Food and Beverages Travel and Tourism Textiles and Clothing SWOT Analysis
Discounts on Market Research Reports till 31st December, 2014 For more inquiries, contact at +91 - 998 729 5242 / contact@jsbmarketresearch.com Table of Content 2 Tourette Syndrome Therapeutics - Introduction 2.1 Overview 2.1.1 Tourette Syndrome Classification Study Group 2.1.2 Classification of Tourette Syndrome 2.2 Etiology and Pathophysiology 2.2.1 Genetic Factors 2.2.2 Autoimmune Factors 2.2.3 Prenatal Difficulties 2.3 Epidemiology 2.3.1 The US 2.3.2 The UK 2.3.3 Italy 2.3.4 France 2.3.5 Germany 2.3.6 Spain Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
2.3.7 Quality of Life 2.3.8 Prognosis 2.3.9 Mortality 2.4 Symptoms 2.4.1 Motor Tics 2.4.2 Phonic Tics 2.4.3 Behavioral Symptoms 2.5 Diagnosis 2.5.1 Diagnostic and Statistical Manual of Mental Disorders - 4th Edition 2.5.2 Differential Diagnosis 2.6 Treatment and Management Pattern 2.6.1 Behavioral Therapy 2.6.2 Pharmacotherapy 2.6.3 Surgical Intervention 2.7 Referral Pathway 2.8 GlobalData Pipeline Report Guidance 3 Tourette Syndrome Therapeutics - Market Characterization 3.1 Tourette Syndrome Therapeutics Market Size 3.2 Tourette Syndrome Therapeutics Market Size (2006-2011) - Global 3.3 Tourette Syndrome Therapeutics Market Forecast (2011-2019) - Global 3.4 Tourette Syndrome Therapeutics Market Size (2006-2011) - The US 3.5 Tourette Syndrome Therapeutics Market Forecast (2011-2019) - The US 3.6 Tourette Syndrome Therapeutics Market Size (2006-2011) - France 3.7 Tourette Syndrome Therapeutics Market Forecast (2011-2019) - France 3.8 Tourette Syndrome Therapeutics Market Size (2006-2011) - Germany 3.9 Tourette Syndrome Therapeutics Market Forecast (2011-2019) - Germany 3.10 Tourette Syndrome Therapeutics Market Size (2006-2011) - Italy 3.11 Tourette Syndrome Therapeutics Market Forecast (2011-2019) - Italy 3.12 Tourette Syndrome Therapeutics Market Size (2006-2011) - Spain 3.13 Tourette Syndrome Therapeutics Market Forecast (2011-2019) - Spain 3.14 Tourette Syndrome Therapeutics Market Size (2006-2011) - The UK 3.15 Tourette Syndrome Therapeutics Market Forecast (2011-2019) - The UK 3.16 Tourette Syndrome Therapeutics Market Size (2006-2011) - Japan 3.17 Tourette Syndrome Therapeutics Market Forecast (2011-2019) - Japan 3.18 Drivers and Barriers 3.18.1 Drivers for the Tourette Syndrome Therapeutics Market 3.18.2 Barriers to the Tourette Syndrome Therapeutics Market 3.19 Opportunity and Unmet Needs 3.20 Key Takeaway Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
4 Tourette Syndrome Therapeutics Market - Competitive Assessment 4.1 Overview 4.2 Strategic Competitor Assessment 4.3 Product Profile for the Major Marketed Products in the Tourette Syndrome Therapeutics Market 4.3.1 Haloperidol 4.3.2 Pimozide 4.4 Key Takeaway 5 Tourette Syndrome Therapeutics - Pipeline Assessment 5.1 Overview 5.2 Strategic Pipeline Assessment 5.3 Pipeline by Phase of Development 5.3.1 Phase III Pipeline 5.3.2 Phase II Pipeline 5.3.3 Phase I Pipeline 5.4 Tourette Syndrome Therapeutics Market - Pipeline by Mechanism of Action 5.5 Technology Trends Analytic Framework 5.6 Promising Drugs Under Development 5.7 Profile of Promising Drug 5.7.1 OPC-14597 (aripiprazole) 5.8 Key Takeaway 6 Tourette Syndrome Therapeutics - Clinical Trials Mapping 6.1 Overview 6.2 Clinical Trials by Region/Country 6.3 Clinical Trials by Phase 6.4 Clinical Trials by Trial Status 6.5 Prominent Sponsors 6.6 Key Companies Participating in Therapeutics Clinical Trials 7 Tourette Syndrome Therapeutics - Strategic Assessment 7.1 Key Events Impacting the Future Market 7.2 Future Market Competition 8 Tourette Syndrome - Future Players 8.1 Introduction 8.2 Company Profiles 8.2.1 Otsuka Holdings Co., Ltd 9 Appendix 9.1 Market Definitions 9.2 Abbreviations 9.3 Methodology Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
9.3.1 Coverage 9.3.2 Secondary Research 9.3.3 Forecasting 9.3.4 Primary Research 9.3.5 Expert Panel Validation 9.4 Contact Us 9.5 Disclaimer 9.6 Bibliography
List Of Tables Table 1: Classification of Tourette Syndrome Based on Clinical Features Table 2: Various Types of Tics Associated with Tourette Syndrome Table 3: Pharmacotherapy Used for Treatment of Tourette Syndrome Table 4: Tourette Syndrome Therapeutics Market, Global, Revenue ($m), 2006-2011 Table 5: Tourette Syndrome Therapeutics Market, Global, Forecast ($m), 2011-2019 Table 6: Tourette Syndrome Therapeutics Market, The US, Revenue ($m), 2006-2011 Table 7: Tourette Syndrome Therapeutics Market, The US, Forecast ($m), 2011-2019 Table 8: Tourette Syndrome Therapeutics Market, France, Revenue ($m), 2006-2011 Table 9: Tourette Syndrome Therapeutics Market, France, Forecast ($m), 2011-2019 Table 10: Tourette Syndrome Therapeutics Market, Germany, Revenue ($m), 2006-2011 Table 11: Tourette Syndrome Therapeutics Market, Germany, Forecast ($m), 2011-2019 Table 12: Tourette Syndrome Therapeutics Market, Italy, Revenue ($m), 2006-2011 Table 13: Tourette Syndrome Therapeutics Market, Italy, Forecast ($m), 2011-2019 Table 14: Tourette Syndrome Therapeutics Market, Spain, Revenue ($m), 2006-2011 Table 15: Tourette Syndrome Therapeutics Market, Spain, Forecast ($m), 2011-2019 Table 16: Tourette Syndrome Therapeutics Market, The UK, Revenue ($m), 2006-2011 Table 17: Tourette Syndrome Therapeutics Market, The UK, Forecast ($m), 2011-2019 Table 18: Tourette Syndrome Therapeutics Market, Japan, Revenue ($m), 2006-2011 Table 19: Tourette Syndrome Therapeutics Market, Japan, Forecast ($m), 2011-2019 Table 20: Tourette Syndrome Therapeutics - Regulatory and Phase III Pipeline, 2011 Table 21: Tourette Syndrome Therapeutics - Phase II Pipeline, 2011 Table 22: Tourette Syndrome Therapeutics - Phase I Pipeline, 2011 Table 23: Tourette Syndrome Therapeutics - Most Promising Drugs Under Development, 2011 Table 24: Tourette Syndrome Therapeutics Market, Clinical Trials by Region, 2011 Table 25: Tourette Syndrome Therapeutics Market, Global, Clinical Trials by Phase of Development, 2011 Table 26: Tourette Syndrome Therapeutics Market, Global, Clinical Trials by Trial Status, 2011 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Table 27: Tourette Syndrome Therapeutics Market, Global, Clinical Trials by Prominent Sponsors, 2011 Table 28: Tourette Syndrome Therapeutics Market, Global, Clinical Trials by Top Companies, 2011 Table 29: Otsuka Holdings Co., Ltd- CNS Pipeline Products, 2011 Table 30: Otsuka Holdings Co., Ltd- Tourette Syndrome Pipeline Products, 2011
List Of Figures Figure 1: Prevalence of Comorbid Conditions Associated with Tourette Syndrome Figure 2: Treatment and Management of Tourette Syndrome Figure 3: Referral Pathway Figure 4: Tourette Syndrome Therapeutics Market, Global, Revenue ($m), 2006-2011 Figure 5: Tourette Syndrome Therapeutics Market, Global, Forecast ($m), 2011-2019 Figure 6: Tourette Syndrome Therapeutics Market, The US, Revenue ($m), 2006-2011 Figure 7: Tourette Syndrome Therapeutics Market, The US, Forecast ($m), 2011-2019 Figure 8: Tourette Syndrome Therapeutics Market, France, Revenue ($m), 2006-2011 Figure 9: Tourette Syndrome Therapeutics Market, France, Forecast ($m), 2011-2019 Figure 10: Tourette Syndrome Therapeutics Market, Germany, Revenue ($m), 2006-2011 Figure 11: Tourette Syndrome Therapeutics Market, Germany, Forecast ($m), 2011-2019 Figure 12: Tourette Syndrome Therapeutics Market, Italy, Revenue ($m), 2006-2011 Figure 13: Tourette Syndrome Therapeutics Market, Italy, Forecast ($m), 2011-2019 Figure 14: Tourette Syndrome Therapeutics Market, Spain, Revenue ($m), 2006-2011 Figure 15: Tourette Syndrome Therapeutics Market, Spain, Forecast ($m), 2011-2019 Figure 16: Tourette Syndrome Therapeutics Market, The UK, Revenue ($m), 2006-2011 Figure 17: Tourette Syndrome Therapeutics Market, The UK, Forecast ($m), 2011-2019 Figure 18: Tourette Syndrome Therapeutics Market, Japan, Revenue ($m), 2006-2011 Figure 19: Tourette Syndrome Therapeutics Market, Japan, Forecast ($m), 2011-2019 Figure 20: Strategic Competitor Assessment of the Major Marketed Products in Tourette Syndrome, 2011 Figure 21: Tourette Syndrome Therapeutics Pipeline by Phase of Development, 2011 Figure 22: Tourette Syndrome Therapeutic Market - Clinical Pipeline by Mechanism of Action 2011 Figure 23: Technology Trends Analytic Framework for the Tourette Syndrome Therapeutics Pipeline, 2011 Figure 24: Technology Trends Analytic Framework for the Tourette Syndrome Therapeutics Pipeline - Description, 2011 Figure 25: Aripiprazole Molecular Structure, 2011 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Figure 26: Clinical Trial Details of Aripiprazole Figure 27: Tourette Syndrome Therapeutics Market, Clinical Trials by Region, 2011 Figure 28: Tourette Syndrome Therapeutics Market, Global, Clinical Trials by Phase of Development, 2011 Figure 29: Tourette Syndrome Therapeutics Market, Global, Clinical Trials by Trial Status, 2011 Figure 30: Tourette Syndrome Therapeutics Market, Global, Clinical Trials by Overall Sponsors (%), 2011 Figure 31: Tourette Syndrome Therapeutics Market, Global, Clinical Trials by Prominent Sponsors, 2011 Figure 32: Tourette Syndrome Therapeutics Market, Global, Clinical Trials by Top Companies, 2011 Figure 33: Tourette Syndrome Therapeutics, Drivers and Barriers, 2011 Figure 34: Implications for Future Market Competition in the Tourette Syndrome Market, 2011 Figure 35: Tourette Syndrome Therapeutics Market - Pipeline by Company, 2011 Figure 36: GlobalData Market Forecasting Model
Report Price: Licence Type
Price
$ 3995
Site Licence
$ 7990
Enterprise Wide Licence
$ 11985
Related Reports: Sarcoidosis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Gauchers Disease Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Skin and Skin Structure Infections (SSSI) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Bile Duct Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Leiomyosarcoma Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Waldenstrms Macroglobulinemia Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Gastrointestinal Stromal Tumors (GIST) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Retinoblastoma Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Growth Hormone Deficiency (GHD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018
You can order this report by calling on +91 - 998 7295 242 or mail us your contact details at contact@jsbmarketresearch.com About JSB Market Research:JSB market research is a leading player in the market of research report distribution. It is onestop-shop for all information related to market research for any sector of the industry. Along with providing in-depth analysis though reports, JSB market research also provides regular updates of the market though newsletters. Our reports are a well-researched work of market researchers with an extensive knowledge and a good level of market experience.
To know more on Tourette Syndrome Therapeutics - Pipeline Assessment and Market Forecasts to 2019 http://www.jsbmarketresearch.com/healthcare-medical/r-tourette-syndrometherapeutics-pipeline-assessment-and-market-forecasts-135218
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/